LEPTIN RECEPTOR DEFICIENCY
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.720 |
strong |
1.000 |
4 |
3
|
1998 |
2019 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
205
|
266
|
0.700 |
None |
0.930 |
10 |
2
|
1966 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
221
|
1232
|
0.600 |
None |
0.975 |
4 |
|
1966 |
2019 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
25
|
1
|
0.540 |
None |
1.000 |
4 |
|
2001 |
2018 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
60
|
53
|
0.500 |
None |
1.000 |
6 |
|
2009 |
2019 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
28
|
5
|
0.420 |
None |
1.000 |
7 |
|
1986 |
2019 |
Hyperphagia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
4
|
3
|
0.400 |
None |
1.000 |
3 |
|
1986 |
2007 |
Primary hypogonadism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
15
|
5
|
0.400 |
None |
1.000 |
1 |
|
2007 |
2007 |
Delayed Puberty
|
phenotype |
Endocrine System Diseases
|
Pathologic Function
|
7
|
21
|
0.400 |
None |
1.000 |
1 |
|
2007 |
2007 |
Obesity, Morbid
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
7
|
1
|
0.400 |
None |
0.944 |
1 |
|
1997 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
538
|
763
|
0.400 |
None |
0.872 |
1 |
|
2006 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
190
|
233
|
0.400 |
None |
1.000 |
1 |
|
2000 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
32
|
118
|
0.400 |
None |
1.000 |
1 |
|
1996 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1074
|
1390
|
0.400 |
None |
0.875 |
1 |
|
2006 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
316
|
0.370 |
None |
1.000 |
1 |
|
2002 |
2014 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
88
|
9
|
0.360 |
None |
1.000 |
2 |
|
2007 |
2020 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
88
|
|
0.350 |
None |
1.000 |
2 |
|
2008 |
2020 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
9
|
20
|
0.350 |
None |
1.000 |
1 |
|
2006 |
2019 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
24
|
|
0.340 |
None |
1.000 |
2 |
|
2010 |
2018 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
30
|
30
|
0.330 |
None |
1.000 |
8 |
|
1986 |
2018 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
|
0.330 |
None |
1.000 |
1 |
|
2014 |
2017 |
Hypogonadotropic hypogonadism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
15
|
1
|
0.330 |
None |
1.000 |
1 |
|
1999 |
2015 |
Fibrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
50
|
|
0.310 |
None |
1.000 |
2 |
|
2006 |
2018 |
Diabetic Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
44
|
33
|
0.310 |
None |
1.000 |
1 |
|
2014 |
2018 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
9 |
|
2004 |
2016 |